Dermatology NewsRilzabrutinib shows positive results in phase 2b for pemphigusJuly 17, 2020Medical Dermatology
Dermatology NewsDoctors say their COVID-19 protocol saves lives; others want proofJuly 17, 2020COVID-19 Updates
Dermatology NewsCOVID-19 pandemic dictates reconsideration of pemphigus therapyJuly 16, 2020COVID-19 UpdatesMixed TopicsMedical Dermatology
Dermatology NewsFour-year-old boy presents with itchy rash on face, extremitiesJuly 16, 2020Pediatrics
Dermatology NewsProvide support in uncertain timesJuly 16, 2020COVID-19 UpdatesPediatricsDiversity in Medicine
Dermatology NewsResidents, fellows will get minimum 6 weeks leave for caregivingJuly 16, 2020Business of MedicinePractice Management
Dermatology NewsCOVID-19: A primary care perspectiveJuly 15, 2020COVID-19 UpdatesInfectious DiseasesPediatrics
Dermatology NewsBe wary of ‘for eczema’ claims on labels of popular moisturizersJuly 15, 2020Atopic DermatitisPediatrics
Dermatology NewsFDA approves Tremfya (guselkumab) for psoriatic arthritisJuly 14, 2020Psoriatic Arthritis
